Koru Medical Systems Inc (KRMD) Stock Price, Quote & News

Latest News on KRMD

Mar 12, 2025, 10:34 PM EDT - 5 weeks ago

KORU Medical Systems, Inc. (KRMD) Q4 2024 Earnings Call Transcript

Mar 12, 2025, 4:05 PM EDT - 5 weeks ago

KORU Medical Systems Announces Fourth Quarter and Full Year 2024 Financial Results With Record Revenues and Gross Profit; Issues Full Year 2025 Guidance

Feb 19, 2025, 4:05 PM EST - 2 months ago

KORU Medical Systems to Report Fourth Quarter and Full Year 2024 Financial Results on March 12, 2025

Feb 10, 2025, 12:11 AM EST - 2 months ago

KORU Medical Systems Has A Long Runway

Feb 6, 2025, 4:05 PM EST - 2 months ago

KORU Medical Systems Announces Agreement for Next-Generation Subcutaneous Immunoglobulin Infusion System

Jan 30, 2025, 4:05 PM EST - 2 months ago

KORU Medical Systems Announces Phase III Clinical Trial Collaboration for a New Drug Indication in Nephrology

Jan 13, 2025, 8:00 AM EST - 3 months ago

KORU Medical Systems Reports Preliminary Fourth Quarter and Full Year 2024 Results; Achieves Record Full Year and Quarterly Revenues; Positive Cash Flow for the Fourth Quarter

Nov 25, 2024, 4:05 PM EST - 5 months ago

KORU Medical Systems to Participate in Piper Sandler's 36th Annual Healthcare Conference

Nov 13, 2024, 6:57 PM EST - 5 months ago

KORU Medical Systems, Inc. (KRMD) Q3 2024 Earnings Call Transcript

Nov 13, 2024, 4:05 PM EST - 5 months ago

KORU Medical Systems, Inc. Announces 2024 Q3 Financial Results, Third Consecutive Quarter of Double-Digit Growth; Raises Full Year 2024 Guidance

Nov 6, 2024, 4:05 PM EST - 5 months ago

KORU Medical Systems to Participate in Upcoming Investor Conferences

Nov 6, 2024, 8:34 AM EST - 5 months ago

Impressive Turnaround At KORU Medical

Oct 31, 2024, 4:03 PM EDT - 6 months ago

KORU Medical Systems Presents Data at Partnership Opportunities in Drug Delivery (PODD) Conference Demonstrating Nursing Preference for Use of KORU FreedomEdge® Infusion System over Manual Syringe Administration for Subcutaneous Oncology Infusion

Oct 23, 2024, 4:05 PM EDT - 6 months ago

KORU Medical Systems to Report Third Quarter 2024 Financial Results on November 13, 2024

Sep 5, 2024, 7:00 AM EDT - 8 months ago

KORU Medical Systems to Participate in the 8th Annual Lake Street Best Ideas Growth Conference

Aug 7, 2024, 8:52 PM EDT - 9 months ago

KORU Medical Systems, Inc (KRMD) Q2 2024 Earnings Call Transcript

Aug 7, 2024, 4:05 PM EDT - 9 months ago

KORU Medical Systems, Inc. Announces 2024 Q2 Financial Results, a Record Quarter With 22% Revenue Growth; Raises Full Year 2024 Guidance

Jul 25, 2024, 4:05 PM EDT - 9 months ago

KORU Medical Systems to Participate in the Canaccord Genuity 44th Annual Growth Conference

Jul 24, 2024, 4:05 PM EDT - 9 months ago

KORU Medical Systems, Inc Announces Leadership Changes to Support Growth Agenda

Jul 17, 2024, 4:05 PM EDT - 9 months ago

KORU Medical Systems to Report Second Quarter 2024 Financial Results on August 7, 2024

Jul 2, 2024, 7:00 AM EDT - 10 months ago

KORU Medical Systems Receives Regulatory Clearance for FreedomEdge® Infusion System in Japan

Jun 5, 2024, 9:00 AM EDT - 11 months ago

Simplifying Subcutaneous Drug Administration: SCHOTT Pharma and KORU Medical Systems Announce Collaboration to Advance Large Volume Subcutaneous Infusion

Jun 4, 2024, 4:03 PM EDT - 11 months ago

KORU Medical Systems Announces a New Feasibility Study with a Commercialized Oncology Biologic

May 14, 2024, 4:05 PM EDT - 1 year ago

KORU Medical Systems Signs Supply Agreement for a Phase III Clinical Trial for a Novel Endocrinological Biologic

May 1, 2024, 10:11 PM EDT - 1 year ago

KORU Medical Systems, Inc. (KRMD) Q1 2024 Earnings Call Transcript

May 1, 2024, 4:05 PM EDT - 1 year ago

KORU Medical Systems, Inc. Announces 2024 First Quarter Financial Results Delivering Double-Digit Revenue Growth

Apr 17, 2024, 7:00 AM EDT - 1 year ago

KORU Medical Systems to Report First Quarter 2024 Financial Results on May 1, 2024

Apr 11, 2024, 4:05 PM EDT - 1 year ago

KORU Medical Systems Announces Successful Appeal in EU Notified Body Review

Mar 18, 2024, 5:24 PM EDT - 1 year ago

KORU Medical Systems to Present Data Demonstrating 97% Adherence on Its Freedom Infusion System for Large Volume Subcutaneous Administration at NHIA 2024 Conference

Mar 13, 2024, 8:27 PM EDT - 1 year ago

KORU Medical Systems, Inc. (KRMD) Q4 2023 Earnings Call Transcript

Mar 13, 2024, 4:05 PM EDT - 1 year ago

KORU Medical Systems, Inc. Announces 2023 Fourth Quarter, Full Year Financial Results, and 2024 Guidance

Mar 11, 2024, 4:05 PM EDT - 1 year ago

KORU Medical Systems Announces a Feasibility Study to Enter Ambulatory Infusion Settings with a Commercialized Biologic

Mar 6, 2024, 7:00 AM EST - 1 year ago

KORU Medical Systems Signs a Clinical Supply Agreement for Phase 3 Trial with Leading Pharma Partner Using Custom Device for a Novel Subcutaneous Immunoglobulin

Feb 21, 2024, 7:00 AM EST - 1 year ago

KORU Medical Systems to Report Fourth Quarter and Full Year 2023 Financial Results on March 13, 2024

Nov 29, 2023, 7:00 AM EST - 1 year ago

KORU Medical Systems to Participate in Piper Sandler's 35th Annual Healthcare Conference

Nov 28, 2023, 8:00 AM EST - 1 year ago

KORU Medical Systems, Inc. to Host Investor Day on December 5, 2023

Nov 8, 2023, 8:12 PM EST - 1 year ago

KORU Medical Systems, Inc. (KRMD) Q3 2023 Earnings Call Transcript

Nov 8, 2023, 4:10 PM EST - 1 year ago

KORU Medical Systems, Inc. Announces Development Agreement for Next-generation Subcutaneous Immunoglobulin Infusion System

Nov 8, 2023, 4:08 PM EST - 1 year ago

KORU Medical Systems, Inc. Appoints Ken Miller as Chief Commercial Officer

Nov 8, 2023, 4:05 PM EST - 1 year ago

KORU Medical Systems, Inc. Announces 2023 Third Quarter Financial Results and Updates Full Year 2023 Outlook

Nov 7, 2023, 4:05 PM EST - 1 year ago

KORU Medical Systems, Inc. Receives FDA 510(k) Clearance for FREEDOM60® Infusion System With Hizentra® 50 ML Prefilled Syringes

Oct 25, 2023, 4:05 PM EDT - 1 year ago

KORU Medical Systems to Report Third Quarter Financial Results on November 8, 2023

Oct 5, 2023, 7:05 AM EDT - 1 year ago

KORU Medical Systems to Present Two Abstracts at the Immunoglobulin National Society 2023 National Conference

Oct 4, 2023, 4:05 PM EDT - 1 year ago

KORU Medical Systems, Inc. Announces Appointment of Edward Wholihan to Its Board of Directors

Sep 15, 2023, 8:05 AM EDT - 1 year ago

KORU Medical Systems to Participate in the Gilmartin Group Emerging Growth Company Showcase

Aug 9, 2023, 8:21 PM EDT - 1 year ago

KORU Medical Systems, Inc. (KRMD) Q2 2023 Earnings Call Transcript

Aug 9, 2023, 4:05 PM EDT - 1 year ago

KORU Medical Systems, Inc. Announces 2023 Second Quarter Financial Results and Updates Full Year 2023 Outlook

Aug 8, 2023, 4:05 PM EDT - 1 year ago

KORU Medical Systems to Participate in the Genuity 43rd Annual Growth Conference

Aug 2, 2023, 5:15 PM EDT - 1 year ago

KORU Medical Systems, Inc. Announces Preliminary Second Quarter 2023 Revenues and Provides Business, Outlook and Executive Updates

Jul 31, 2023, 4:05 PM EDT - 1 year ago

Market Cap	104.32M
Revenue (ttm)	33.65M
Net Income (ttm)	-6.07M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-18.04%
Debt to Equity Ratio	0.00

Volume	106,187
Avg Vol	173,846
Day's Range	N/A - N/A
Shares Out	45.96M
Stochastic %K	57%
Beta	0.87
Analysts	Strong Sell
Price Target	$5.50